Bharat Serums And Vaccines Profile
Key Indicators
- Authorised Capital ₹ 21.95 Cr
as on 04-10-2024
- Paid Up Capital ₹ 9.01 Cr
as on 04-10-2024
- Company Age 53 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 427.21 Cr
as on 04-10-2024
- Revenue -0.11%
(FY 2021)
- Profit 86.62%
(FY 2021)
- Ebitda 47.62%
(FY 2021)
- Net Worth 17.42%
(FY 2021)
- Total Assets 21.00%
(FY 2021)
About Bharat Serums And Vaccines
- CIN/LLPIN
U24230MH1971PLC015134
- Company No.
015134
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Apr 1971
- Date of AGM
27 Aug 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bharat Serums And Vaccines Limited offer?
Bharat Serums And Vaccines Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Fragrance Chemicals, Common Disease Medicines, Injectable Products, Fertility Enhancer, Menotropins Injection, Vaccines, Rhoclone Injection, Pharmaceutical Injectables, Diagnostic Medical Imaging Equipment.
Who are the key members and board of directors at Bharat Serums And Vaccines?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Navangul  | Managing Director | 07-Feb-2020 | Current |
| Anupama Pai | Company Secretary | 14-Nov-2020 | Current |
| Chirag Mehta | CFO | 15-Jul-2020 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Patwari | Director | 07-Feb-2020 | Current |
| Gautam Daftary | Director | 01-Oct-2011 | Current |
| Bharat Daftary | Director | 05-May-1992 | Current |
| Shweta Jalan | Director | 07-Feb-2020 | Current |
| Bhaskar Iyer | Director | 07-Feb-2020 | Current |
| Jayesh Merchant | Director | 07-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Bharat Serums And Vaccines.
Bharat Serums And Vaccines Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.11% decrease. The company also saw a substantial improvement in profitability, with a 86.62% increase in profit. The company's net worth Soared by an impressive increase of 17.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bharat Serums And Vaccines?
In 2021, Bharat Serums And Vaccines had a promoter holding of 76.87% and a public holding of 23.13%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharat Serums And Vaccines LimitedActive 31 years 1 monthShweta Jalan, Bhaskar Iyer and 6 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Aug 2017 | ₹36.80 Cr | Satisfied |
Others Creation Date: 21 Nov 2014 | ₹35.00 Cr | Satisfied |
Export-Import Bank Of India Creation Date: 22 Mar 2013 | ₹20.00 Cr | Satisfied |
How Many Employees Work at Bharat Serums And Vaccines?
Unlock and access historical data on people associated with Bharat Serums And Vaccines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bharat Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Serums And Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
